Eli Lilly
LLY
LLY
3,250 hedge funds and large institutions have $464B invested in Eli Lilly in 2023 Q4 according to their latest regulatory filings, with 432 funds opening new positions, 1,210 increasing their positions, 1,229 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,250
Holders Change
+292
Holders Change %
+9.87%
% of All Funds
47.65%
Holding in Top 10
301
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
4.41%
New
432
Increased
1,210
Reduced
1,229
Closed
96
Calls
$4.99B
Puts
$5.55B
Net Calls
-$558M
Net Calls Change
-$245M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$14.8B |
| 2 |
2
JPMorgan Chase & Co
New York
|
$11.3B |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$41.7B |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$1.94B |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$19.1B |
Top Sellers
| 1 |
1
BlackRock
New York
|
$37.5B |
| 2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$6.87B |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$5.32B |
| 4 |
4
Primecap Management
Pasadena,
California
|
$12.9B |
| 5 |
5
Jennison Associates
New York
|
$4.43B |
